Tenderwize
Retour à la recherche

Lotto 1

InnovaPuglia S.p.A.·Valenzano, Italy·EUR 5500M·Deadline Jun 18, 2029 · 986 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
High valueStructured notice only
Titre original de l'avis

Italy – Pharmaceutical products – Bando SDA FARMACI 2025 - Prodotti Farmaceutici

70/100

Score d'opportunité

PromisingMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

70 / 100

Complexité

55 / 100

Facteurs de risque

Only one selection criterion is provided (trade register registration). Other eligibility criteria (e.g., financial, te...

The estimated value is extremely high, but it may be a ceiling for the DPS; actual awarded contracts could be lower.

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
InnovaPuglia S.p.A.
Pays
Italie
CPV
33600000 - Pharmaceutical products
Date limite
Jun 18, 2029
Valeur estimée
EUR 5500M

Aperçu

Strong opportunity

Faits clés

  • EUR 5500M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration 1461 DAY
  • Supply of pharmaceutical products (CPV 33600000) to healthcare companies in the Puglia region, Italy.
  • The DPS is open for submission of indicative tenders until 18 June 2029.
Afficher le résumé complet

This notice establishes a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products to healthcare companies in the Puglia region of Italy. The DPS is valued at €5.5 billion and will run for approximately 4 years (until June 2029). It is a restricted procedure with electronic submission required in Italian. Only one lot is defined. The award is based on the most economically advantageous tender (quality criteria). Selection requires registration in the trade register.

Risques

Only one selection criterion is provided (trade register registration). Other eligibility criteria (e.g., financial, te...

The estimated value is extremely high, but it may be a ceiling for the DPS; actual awarded contracts could be lower.

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Registration in the trade register (required for participation).

Administrative

  • Electronic submission via the e-procurement platform (eproc.empulia.it).
  • All communications and documents must be in Italian.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Offerta economicamente più vantaggiosa

Acheteur

Localisation

Valenzano, ITA

Profil acheteur

Ouvrir le profil

Identifiant

06837080727

Activité

General public services

Lots (1)

LOT-0001

Lotto 1

Supply of pharmaceutical products to healthcare companies in Puglia (NUTS: ITF47). The lot is part of a DPS; no specific individual tender deadline is provided. Estimated value: €5,500,000,000.

SuppliesDPSEU fundedElectronic submission

EUR 5.5B

Valeur estimée

Localisation

ITF47, Italy

Durée

1461 DAY

Catégorie

Pharmaceutical products

Critères d'attribution

Offerta economicamente più vantaggiosa

Date limite

Deadline Jun 18, 2029

Détails de la procédure

Date de publication
19 Jun 2025
Langues
Italian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
400352-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

Dec 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30